Triptolide Down-regulates COX-2 Expression and PGE2 Release by Suppressing the Activity of NF-κB and MAP kinases in Lipopolysaccharide-treated PC12 Cells

The role of neuroinflammation on the pathogenesis of Parkinson's disease

(2011) Young-Cheul Chung et al.   BMB Reports

Extract of Tripterygium wilfordii Hook F Protect Dopaminergic Neurons Against Lipopolysaccharide-Induced Inflammatory Damage

(2010) Yuxin Liu et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease

(2009) Tuan Hoang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Cyclooxygenase Inhibition in Ischemic Brain Injury

(2008) Eduardo Candelario-Jalil et al.   CURRENT PHARMACEUTICAL DESIGN

Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles

(2008) Lingyun Xu et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Triptolide inhibits amyloid-β1-42-induced TNF-α and IL-1β production in cultured rat microglia

(2008) Jian Jiao et al.   JOURNAL OF NEUROIMMUNOLOGY

Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis

(2008) Ying Wang et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: Implication for immunosuppressive therapy in Parkinson’s disease

(2008) Jun-Peng Gao et al.   Neuroscience Bulletin